The pediatric cardiology pharmacopoeia: 2004 update.
Seven years ago, Pediatric Cardiology published the first version of a review article outlining the various medications used in the field of heart diseases in children. This article is an update and expansion to what we have previously presented. Therapeutic intervention, both surgical and through cardiac catheterization, has enabled cure and palliation of an increasingly expanding spectrum of diseases at earlier ages and with more complex lesions. Refinement of these procedures includes more advanced tools as well as the support of an expanding armament of pharmacopoeia used to stabilize and support patients before, during, and after such procedures. In addition to updating previously published data regarding inotropes, antiarrhythmics, vasodilators, diuretics, sedatives, and analgesics as well as a variety of miscellaneous medications, this article describes the use of pulmonary medications frequently needed in patients with congestive heart failure, pulmonary edema, and chronic lung disease. We also describe the difficult management of withdrawal as a result of use of sedatives and analgesics. The most recent recommendation for subacute bacterial endocarditis prophylactic antibiotic regimens is also described.
Barnes
S
S
Department of Pediatrics and Anesthesiology, Rush Medical College, Chicago, IL, USA.
Shields
B
B
Bonney
W
W
Hardin
J
J
Abdulla
R
R
D002309:Cardiology / Q000592:standards; D002317:Cardiovascular Agents / Q000627:therapeutic use; D002492:Central Nervous System Depressants / Q000627:therapeutic use; D006331:Heart Diseases / Q000188:drug therapy; D006801:Humans; D008171:Lung Diseases / Q000188:drug therapy; D010372:Pediatrics / Q000592:standards; D010602:Pharmacopoeias as Topic; D017410:Practice Guidelines as Topic
D002317:Cardiovascular Agents; D002492:Central Nervous System Depressants